Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCR1 is a G-protein-coupled receptor and a high-affinity receptor for interleukin-8 (IL-8, CXCL8). It is predominantly expressed on neutrophils and plays a critical role in neutrophil chemotaxis, activation, and inflammatory responses. It also contributes to angiogenesis and tumor growth, making it a therapeutic target for various diseases including cancer and inflammatory disorders.
Inhibition/blockade of CXCR1 to reduce neutrophil recruitment and inflammatory responses; prevention of angiogenesis and tumor growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C Chemokine Receptor Type 1 (CXCR1).